CD163 and diffuse large B-cell lymphoma: Notably, the VSIG4 expression in the DLBCL TME was heterogeneous; in one VSIG4+ DLBCL case, most CD68+/CD163+ cells expressed VSIG4, while in another, only a focal subset did.